ALEGLITAZAR LOWERS THE TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors :: Michael Rabbia
Stephen J. Nicholls
Robert R. Henry
Matthias Herz
Sylvie Meyer Reigner
Source :: Journal of the American College of Cardiology. 59:E1661
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
Aleglitazar
Triglyceride
business.industry
Cholesterol
Type 2 Diabetes Mellitus
chemistry.chemical_compound
Endocrinology
High-density lipoprotein
chemistry
Internal medicine
medicine
In patient
Cardiology and Cardiovascular Medicine
business

Full Text Access

Tools